Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 313

1.

Safety of salmeterol in the maintenance treatment of asthma.

Nathan RA, Seltzer JM, Kemp JP, Chervinsky P, Alexander WJ, Liddle R, Mills R.

Ann Allergy Asthma Immunol. 1995 Sep;75(3):243-8.

PMID:
7552926
2.

A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma.

Pearlman DS, Chervinsky P, LaForce C, Seltzer JM, Southern DL, Kemp JP, Dockhorn RJ, Grossman J, Liddle RF, Yancey SW, et al.

N Engl J Med. 1992 Nov 12;327(20):1420-5.

3.

The safety of twice-daily treatment with fluticasone propionate and salmeterol in pediatric patients with persistent asthma.

Malone R, LaForce C, Nimmagadda S, Schoaf L, House K, Ellsworth A, Dorinsky P.

Ann Allergy Asthma Immunol. 2005 Jul;95(1):66-71.

PMID:
16095144
4.

A 1-week dose-ranging study of inhaled salmeterol in patients with asthma.

Bronsky EA, Kemp JP, Orgel HA, Bierman CW, Tinkelman DG, van As A, Liddle RF.

Chest. 1994 Apr;105(4):1032-7.

PMID:
7909285
5.

Long-acting beta 2-agonist salmeterol compared with albuterol in maintenance asthma therapy.

Pearlman DS.

Ann Allergy Asthma Immunol. 1995 Aug;75(2):180-4.

PMID:
7648385
6.

A one-week dose-ranging study of inhaled salmeterol in children with asthma.

Weinstein S, Chervinsky P, Pollard SJ, Bronsky EA, Nathan RA, Prenner B, Howland WC 3rd, Stahl E, Liddle R.

J Asthma. 1997;34(1):43-52.

PMID:
9033439
8.

Efficacy, safety, and impact on quality of life of salmeterol in patients with moderate persistent asthma.

Busse WW, Casale TB, Murray JJ, Petrocella V, Cox F, Rickard K.

Am J Manag Care. 1998 Nov;4(11):1579-87.

9.

Salmeterol versus theophylline in the treatment of asthma.

Pollard SJ, Spector SL, Yancey SW, Cox FM, Emmett A.

Ann Allergy Asthma Immunol. 1997 May;78(5):457-64.

PMID:
9164358
10.

Comparison of powder and aerosol formulations of salmeterol in the treatment of asthma.

Wolfe J, Kreitzer S, Chervinsky P, Lawrence M, Wang Y, Reilly D, Davis S, Stahl E.

Ann Allergy Asthma Immunol. 2000 Mar;84(3):334-40.

PMID:
10752919
11.

A twelve-week comparison of salmeterol and salbutamol in the treatment of mild-to-moderate asthma: a Canadian multicenter study.

Boulet LP, Laviolette M, Boucher S, Knight A, H├ębert J, Chapman KR.

J Allergy Clin Immunol. 1997 Jan;99(1 Pt 1):13-21.

PMID:
9003206
12.

Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.

D'Alonzo GE, Nathan RA, Henochowicz S, Morris RJ, Ratner P, Rennard SI.

JAMA. 1994 May 11;271(18):1412-6.

PMID:
7909853
13.

Concurrent use of salmeterol with inhaled corticosteroids is more effective than inhaled corticosteroid dose increases.

Murray JJ, Church NL, Anderson WH, Bernstein DI, Wenzel SE, Emmett A, Rickard KA.

Allergy Asthma Proc. 1999 May-Jun;20(3):173-80.

PMID:
10389550
14.

Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.

Blake K, Pearlman DS, Scott C, Wang Y, Stahl E, Arledge T.

Ann Allergy Asthma Immunol. 1999 Feb;82(2):205-11.

PMID:
10071526
15.

Combined salmeterol/fluticasone propionate versus fluticasone propionate alone in mild asthma : a placebo-controlled comparison.

Boonsawat W, Goryachkina L, Jacques L, Frith L.

Clin Drug Investig. 2008;28(2):101-11.

PMID:
18211118
19.

Efficacy, safety, and effects on quality of life of salmeterol versus albuterol in patients with mild to moderate persistent asthma.

Wenzel SE, Lumry W, Manning M, Kalberg C, Cox F, Emmett A, Rickard K.

Ann Allergy Asthma Immunol. 1998 Jun;80(6):463-70.

PMID:
9647268
20.

A short-term comparison of fluticasone propionate/salmeterol with ipratropium bromide/albuterol for the treatment of COPD.

Donohue JF, Kalberg C, Emmett A, Merchant K, Knobil K.

Treat Respir Med. 2004;3(3):173-81.

PMID:
15219176
Items per page

Supplemental Content

Write to the Help Desk